Human glioblastoma ADF cells express tyrosinase, L-tyrosine hydroxylase and melanosomes and are sensitive to L-tyrosine and phenylthiourea

Journal of Cellular Physiology

Volumn 207, Issue 3, 2006, Pages 675-682

  Bonfigli, Antonella ^a   Zarivi, Osvaldo ^a   Colafarina, Sabrina ^a   Cimini, Anna Maria ^a   Ragnelli, Anna Maria ^a   Aimola, Pierpaolo ^a   Natali, Pier Giorgio ^b   Cerù, Maria Paola ^a   Amicarelli, Fernanda ^a   Miranda, Michele ^a,c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c Department of Basic and Applied Biology ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOPHENOL MONOOXYGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHENYLTHIOUREA; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SEMIQUINONE; TRANSCRIPTION FACTOR; TYROSINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CATECHOLAMINE SYNTHESIS; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENOTOXICITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MELANOCYTE; MELANOGENESIS; MELANOSOME; NEUROBLAST; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CASPASE 9; CASPASES; CELL LINE, TUMOR; FORMALDEHYDE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MELANOSOMES; MICROSCOPY, ELECTRON; MONOPHENOL MONOOXYGENASE; NEUROBLASTOMA; NF-KAPPA B; PHENYLTHIOUREA; PPAR ALPHA; RNA, MESSENGER; TYROSINE; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 33646363034     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20603     Document Type: Article

References (31)

1. Chitturi S, Farrell GC. 2001. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 21(1):27-41.
2. Graham DG. 1979. On the origin and significance of neuromelanin. Arch Pathol Lab Med 103:359-362.
3. Greggio E, Bergantino E, Carter D, Ahmad R, Costin G, Hearing VJ, Clarimon J, Singleton A, Eerola J, Hellström O, Tienari PJ, Miller DW, Beilina A, Bubacco L, Cookson MR. 2005. Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease. J Neurochem 93:246-256.
4. Halaban R, Lerner AB. 1977. Tyrosinase and inhibition on proliferation of melanoma cells and fibroblasts. Exp Cell Res 108:119-125.
5. Higashi Y, Asanuma M, Miyazaki I, Ogawa N. 2000. Inhibition of tyrosinase reduces cell viability in catecholaminergic neuronal cells. J Neurochem 75(4): 1771-1774.
6. Hochstein P, Cohen G. 1963. The cytotoxicity of melanin precursor. Ann NY Acad Sci 100:876-886.
7. Jenner P. 2003. Oxidative stress in Parkinson's disease. Ann Neurol 53(S3): 26-38.
8. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
9. Lode HN, Bruchelt G, Seitz G, Gebhardt S, Gekeler V, Niethammer D, Beck J. 1995. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: Correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression. Eur J Cancer 31A(4):586-590.
10. Loring J, Glimelius B, Weston JA. 1982. Extracellular matrix materials influence quail neural crest cell differentiation in vitro. Dev Biol 90:165-174.
11. Miranda M, Botti D, Bonfigli A, Ventura T, Arcadi A. 1984. Tyrosinase-like activity in normal human substantia nigra. Gen Pharmacol 15:541-544.
12. Miranda M, Amicarelli F, Bonfigli A, Poma A, Zarivi O, Arcadi A. 1990. Mutagenicity test for unstable compounds, such as 5,6-dihydroxyindole, using an Escherichia coli HB101/pBR322 transfection system. Mutagenesis 5(3): 251-255.
13. Nichols DH, Kaplan A, Weston JA. 1977. Melanogenesis in cultures of peripheral nervous tissue. Dev Biol 60:226-237.
14. O'Malley KL, Anhalt MJ, Martin BM, Kelsoe JR, Winfleld SL, Ginns EI. 1987. Isolation and characterization of the human tyrosine hydroxylase gene: Identification of 5′ alternative splice sites responsible for multiple mRNAs. Biochemistry 26:6910-6914.
15. Pawelek JR, Lerner AB. 1978. 5,6-dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature 276:627-628.
16. Pearse AGE. 1985. Histochemistry Theoretical and Applied. Edinburgh, London, Melbourne, New York: Churchill Livingstone. (2) p. 963.
17. Pearse AGE. 1985. Histochemistry Theoretical and Applied. Edinburgh, London, Melbourne, New York: Churchill Livingstone. (2) pp. 959-960.
18. Pitrak DL, Tsai HC, Mullane KM, Sutton SH, Stevens PJ. 1996. Clin Invest 98:2714-2719.
19. Reynolds ES. 1963. The use of lead citrate at high pH as an electron opaque stain in electron microscopy. J Cell Biol 17:208-212.
20. Rodgers AD, Curzon G. 1975. Melanin formation by human brain in vitro. J Neurochem 24:1123-1129.
21. Ross RA, Biedler JL. 1985. Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro. Cancer Res 45:1628- 1632.
22. Ross RA, Spengler B, Biedler L. 1983. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. JNCI 71:4.
23. Ross RA, Spengler BA, Domenech C, Porubcin M, Rettig WJ, Biedler JL. 1995. Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ 6(4):449-456.
24. Seil FJ, Johnson ML, Nishi R, Nilaver G. 1992. Tyrosine hydroxylase expression in non-catecholaminergic cells in cerebellar cultures. Brain Res 569(1):164-168.
25. Studzinski GP. 1999. Cell Growth and Apoptosis. Oxford New York Tokyo: Oxford University press, p. 181.p
26. Tief K, Schmidt A, Beermann F. 1998. New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain. Mol Brain Res 53:307-310.
27. Towbin H, Staehelin T, Gordon L. 1979. Electrophoretic transfer of proteins from gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76:4350-4354.
28. Vetulani J, Reichenberg K, Wiszniowska G, Marchaj J. 1973. The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain. Pol J Pharmacol Pharm 25(6): 559-572.
29. Xu Y, Stokes AH, Freeman WM, Kumer SC, Vogt BA, Vrana KE. 1997. Tyrosinase mRNA is expressed in human substantia nigra. Mol Brain Res 45:159-162.
30. Xu Y, Stokes AH, Roskoski EJ, Vrana KE. 1998. Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase. J Neurosci Res 54:691-697.
31. Zhang J, Price JO, Graham DG, Montine TJ. 1998. Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures. Biochem Biophys Res Commun 248(3):812-816.